Research Article
Clinical Manifestations Vary with Different Age Spectrums in Infants with Kawasaki Disease
Table 1
Incidence and clinical manifestations.
| Variable | Group 1 () | Group 2 () | Group 3 () | value | Group 1 versus group 2 | Group 1 versus group 3 | Group 2 versus group 3 |
| Days between disease onset to diagnosis, mean ± SD | | | | 0.006† | 0.010† | 0.506 | M/F | 24/6 | 26/9 | 45/35 | 0.803 | 0.038† | 0.105 | Fulfill diagnosis criteria in 10 days, (%) | 11 (37%) | 23 (66%) | 64 (80%) | 0.037† | <0.001† | 0.160 | Incomplete Kawasaki disease, (%) | 19 (63%) | 12 (34%) | 16 (20%) | 0.037† | <0.001† | 0.160 |
| Major criteria |
| Fever > 5 days, (%) | 30 (100%) | 33 (94%) | 75 (94%) | 0.945 | 0.375 | 0.754 | Bilateral bulbar conjunctiva injection, (%) | 25 (83%) | 35 (100%) | 75 (94%) | 0.017† | 0.187 | 0.310 | Change in mucosa of oropharynx, (%) | 26 (87%) | 32 (91%) | 73 (91%) | 0.695 | 0.721 | 0.743 | Change of the extremities, (%) | 12 (40%) | 18 (51%) | 40 (50%) | 0.502 | 0.471 | 0.951 | Skin rash, (%) | 27 (90%) | 32 (91%) | 73 (91%) | 1.00 | 0.866 | 0.743 | Lymphadenopathy, (%) | 4 (13%) | 12 (34%) | 51 (64%) | 0.096 | <0.001† | 0.007† |
| Other clinical manifestations |
| Upper respiratory tract infection, (%) | 18 (60%) | 21 (60%) | 35 (44%) | 0.800 | 0.192 | 0.161 | Diarrhea/vomiting, (%) | 12 (40%) | 14 (40%) | 19 (24%) | 0.800 | 0.147 | 0.121 | Sterile pyuria, (%) | 14 (40%) | 14 (40%) | 16 (20%) | 0.772 | 0.011† | 0.044† | Perianal desquamation, (%) | 7 (23%) | 2 (6%) | 16 (20%) | 0.096 | 0.905 | 0.097 |
|
|
†Statistical significance.
|